BSE filing, NSE: SAMRATPH. Summary written from the filing by ALFA Finder's alert engine.
Samrat Pharmachem Ltd: key numbers
- Share price
- ₹261.10
- Market cap
- ₹80.67 Cr
- Revenue (annual)
- ₹289.7 Cr
- Net profit (annual)
- ₹-3.31 Cr
- P/E (TTM)
- -36.5×Sector 48.7×
- Promoter holding
- 49.09%+0.00% QoQ
- FII holding
- 3.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Samrat Pharmachem Ltd
All →Samrat Pharmachem Other Announcement
Samrat Pharmachem Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations. This is a routine compliance disclosure detailing the company's ownership structure.
Samrat Pharmachem Board Meeting Date
Samrat Pharmachem will hold a board meeting on November 14, 2026, to consider its unaudited quarterly financial results for the period ended September 2026.
Samrat Pharmachem Other Announcement
Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.
Samrat Pharmachem Annual General Meeting
Samrat Pharmachem Limited held its 34th Annual General Meeting on September 23, 2026. The meeting successfully transacted the business items outlined in the prior meeting notice.
Samrat Pharmachem Annual Report
Samrat Pharmachem filed its 34th Annual Report for FY 2025-26. The company's 34th AGM is scheduled for September 23, 2026, via video conferencing.
Samrat Pharmachem Q1 FY27 Results: Turns Profitable, Net Profit ₹0.9 Cr
Samrat Pharmachem Ltd reported revenue from operations of ₹79.8 Cr (+5.4% YoY) and net profit of ₹0.9 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.9 Cr
Other annual general meeting announcements
All →Ashapuri Gold Ornament Annual General Meeting
Ashapuri Gold Ornament held its 18th AGM on 30 October 2026, transacting eight resolutions including auditor appointment and remuneration revisions. No transaction value is disclosed.
Wealth First Portfolio Managers Annual General Meeting
EGM notice seeks approval for preferential allotment and a ₹60 Crore RPT cap with Lakshya Asset Management. Meeting scheduled for November 21, 2026 via video conference.
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Uravi Defence and Technology Annual General Meeting
Uravi Defence seeks postal ballot approval for up to Rs.6 Crore unsecured loans from directors. Remote e-voting runs October 30 to November 28, 2026.
Accord Synergy Annual General Meeting
Accord Synergy's postal ballot seeks approval for Mr. Betulla Khan's ₹5 lakh monthly remuneration as Business Development Head. E-voting closes November 30, 2026.
- Execution
- 1 year, 17 September 2026 to 16 September 2027
Globe Multi Ventures Annual General Meeting
Globe Multi Ventures filed proceedings of its 41st AGM held on October 29, 2026. E-voting results will follow after the scrutinizer's report.